News

STARHAUS Open Calls on Open Innovation and Creativity

Published on | 11 months ago

Programmes Culture and society Digital, Industry & Space New European Bauhaus

STARHAUS is an innovative project funded by Horizon Europe. This project aims to facilitate the widespread community adoption of sustainable customized fast moving consumer goods through a human-centered approach for a decentralized, localized and urban manufacturing.

The STARHAUS project has recently launched two open calls via Cascade Funding or Financial Support for Third Parties.

To find more detailed information on the calls click on the relevant call which will lead you to a webpage with more information about the call.

The call deadline is 27 January 2025, 17:00 CET.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1747 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.